When a hospital is mid-renovation, the chaos is visible: the hoardings, the noise, the detours through unfamiliar corridors. What is far less visible, and far more dangerous for certain patients, is what might be travelling through the air. That invisible risk became tragically real at Sydney's Royal Prince Alfred Hospital late last year, when a fungal infection cluster swept through the transplant unit, killing two people and affecting six patients in total.
The outbreak occurred between October and December 2025, according to the Sydney Local Health District, and has been directly linked to the hospital's ongoing $940 million redevelopment. The culprit was Aspergillus, a common mould found in soil, dust, and damp environments. For most people, exposure to Aspergillus causes little or no harm. For patients who are severely immunocompromised, including those who have recently undergone organ transplants, it can be fatal.
A spokesperson for the Sydney Local Health District acknowledged the devastating outcome and offered condolences to the affected families. "Fungal infections are a known risk for patients who are significantly immunocompromised, including patients undergoing organ transplant procedures," the spokesperson said, adding that the district "extends its deepest condolences to the families of the patients who died at Royal Prince Alfred Hospital and acknowledges the impact on all patients and families."
Once the outbreak was identified, infectious disease clinicians launched an investigation. The response included a deep clean of the transplant ward, upgrades to air filtration systems, and comprehensive air quality testing. Patients were relocated from the affected ward while remediation work was carried out, and at-risk individuals were placed on antifungal medication following clinical consultation.
NSW Chief Health Officer Kerry Chant convened an expert panel to assess the risk and guide the reopening decision. That panel declared the ward safe to reopen on 9 February. The district has since stated that "robust policies and procedures" are now in place to prevent a recurrence, and reaffirmed RPA's standing as a centre of excellence in transplant medicine, with close to 60 years of kidney transplant experience and 40 years in liver transplants.
The link between construction activity and fungal infection in hospitals is well documented in medical literature. Aspergillus spores are routinely disturbed by earthworks and demolition, and infection control guidelines published by bodies including the World Health Organisation specifically address the need for protective barriers and air filtration in clinical areas adjacent to building works. The question this outbreak raises is not whether the risk was known, but whether sufficient precautions were taken before infections occurred.
From a patient safety perspective, that is the central accountability question. Major hospital redevelopments carry undeniable public benefit, modernising ageing infrastructure and expanding capacity. But the management of infection risk during construction requires careful, ongoing oversight, not simply a reactive response after harm has occurred. Families of the deceased deserve a transparent account of what protections were in place and when they were strengthened.
The Australian Commission on Safety and Quality in Health Care maintains national standards on infection prevention, including requirements for managing construction-related risks in clinical environments. Whether those standards were met throughout the RPA redevelopment period will likely be a focus of any formal review. The district's decision to publicise the outbreak and outline its remediation steps is a reasonable starting point for public accountability, though it will not be the end of the conversation.
RPA remains one of Australia's most important hospitals, and the work done in its transplant unit saves lives that would otherwise be lost. Holding that fact alongside the grief of two families, and the reasonable expectation that a building project should never compromise the safety of the most vulnerable patients, is genuinely difficult. Getting that balance right is what hospital administration, government oversight, and infection control expertise exist to do. This outbreak is a reminder of the stakes when any of those systems falls short.